Now showing items 1-1 of 1

    • Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens. 

      Asbach, B; Kliche, A; Köstler, J; Perdiguero, B; Esteban, M; Jacobs, BL; Montefiori, DC; LaBranche, CC; Yates, NL; Tomaras, GD; Ferrari, G; Foulds, KE; Roederer, M; Landucci, G; Forthal, DN; Seaman, MS; Hawkins, N; Self, SG; Sato, A; Gottardo, R; Phogat, S; Tartaglia, J; Barnett, SW; Burke, B; Cristillo, AD; Weiss, DE; Francis, J; Galmin, L; Ding, S; Heeney, JL; Pantaleo, G; Wagner, R (J Virol, 2016-04)
      UNLABELLED: In a follow-up to the modest efficacy observed in the RV144 trial, researchers in the HIV vaccine field seek to substantiate and extend the results by evaluating other poxvirus vectors and combinations with DNA ...